Citizens Financial Group Inc Vericel Corp Transaction History

Citizens Financial Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$46.35 - $59.75 $234,762 - $302,633	-5,065 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$47.2 - $67.81 $239,068 - $343,457	5,065 New	5,065 $266,000
Q3 2020 Nov 12, 2020	SELL	$14.68 - $19.12 $74,354 - $96,842	-5,065 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$7.25 - $19.22 $36,721 - $97,349	5,065 New	5,065 $46,000

276

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.48B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Citizens Financial Group Inc with notifications on news.